FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications

The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications – which can facilitate weight loss – over a rare eye condition that could lead to sudden and permane...

Source: [Guardian World](https://www.theguardian.com/us-news/2026/nov/10/fda-glp-1-weight-loss-blindness-risk)